The OIG has released two reports focusing on dietary supplements, one examining labeling claims and the other reviewing the FDA’s ability to identify and contact manufacturers in a public health emergency. In the first report, “Dietary Supplements: Structure/Function Claims Fail to Meet Federal Requirements,” the OIG analyzed structure/function claims for a sample of
Dietary Supplements
Congressional Hearings
By Debra A. McCurdy on
Recent Congressional hearings include a Senate Special Committee on Aging hearing on dietary supplements, a House Energy and Commerce Committee hearing on “Developments in Synthetic Genomics and Implications for Health and Energy,” and a House Oversight and Government Reform Committee hearing on “Pediatric Over-the-counter Medication Recalls.”